RE:what supports share priceI'll try .
Market cap is $604.3 million.
- Total revenue increased 12% to $171.2 million compared to $152.4 million in fiscal 2023.
Expected revenue growth of 7-9% gives $186.6 million.
For simplicity's sake , lets call it 3 times sales which isn't terribly overpriced , maybe even fairly priced.
They do have very desirable hospital supply chain business in which they are the market leader for which there would be many purchasers IMO.
The bad is they aren't a sole focus company -having bought companies pre covid which didn't hurt them .
Their margins are low which i can't figure out .